Innoviva (INVA)
Funds hospital critical-care and infectious-disease drugs with GSK respiratory royalties.
$20.96
vs last close−0.02 (−0.10%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 104.89% | 75.78M shares | |
|---|---|---|---|
| 310 holders · as of Jun 30, 2026 | |||
| Insiders | 9.11% | 6.58M shares | |
| 9 holders · as of Aug 24, 2026 | |||
| Adds to | 114.00% | ||
72.25M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 114.00%; nothing is left for Other.
13F, as of Jun 30, 2026
310 holders · 75.78M shares · 47 new positions · 180 increased · 84 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 11.56M | 15.99% | +247.4K | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 4.49M | 6.22% | +57.6K | Aug 11, 2026 |
| Vanguard Portfolio Management LLC | 4.22M | 5.84% | −4.7K | Aug 13, 2026 |
| Renaissance Technologies LLC | 4.04M | 5.59% | −19.1K | Aug 13, 2026 |
| State Street Corp | 3.27M | 4.52% | +207.6K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 3.16M | 4.37% | +16.5K | Aug 13, 2026 |
| Millennium Management LLC | 2.54M | 3.52% | +261.7K | Aug 14, 2026 |
| Geode Capital Management, LLC | 2.07M | 2.87% | +145.0K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.00% | 8.79M | 13G | Apr 28, 2025 |
| Dimensional Fund Advisors LP | 5.80% | 4.36M | 13G | Jan 21, 2026 |
| Vanguard Portfolio Management | 5.79% | 4.29M | 13G | Apr 29, 2026 |
| Renaissance Technologies LLC | 5.63% | 4.21M | 13G | Feb 12, 2026 |
| Vanguard Capital Management | 5.01% | 3.70M | 13G | Jul 31, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.